AVITA Medical RCEL
NASDAQ RCEL
$10.16 -0.25 (-2.40%)
As of: Sep 9, 2026 · 3:59 PM EDT

AVITA Medical, Inc. (RCEL) Work In Process (2021 - 2022)

AVITA Medical's (RCEL) quarterly Work In Process came in at $384000.0 in Q4 2022, up 118.18% on a YoY basis from $176000.0 in Q4 2021, and up 118.18% quarter-over-quarter from $176000.0 in Q4 2021.

Analysis

AVITA Medical, Inc. (RCEL) Work In Process (2021 - 2022) Analysis & Trends

AVITA Medical (RCEL) has reported Work In Process for 2 consecutive years, with $384000.0 the latest figure, recorded in Q4 2022.

  • For the quarter ending Q4 2022, Work In Process rose 118.18% year-over-year to $384000.0; the trailing twelve-month figure through Dec 2022 stood at $384000.0 (up 118.18% YoY), and the FY2022 full-year result was $384000.0, up 118.18% from the prior year.
  • Work In Process advanced to $384000.0 in Q4 2022 per RCEL's latest filing, from $176000.0 in the prior quarter.
  • Across five years, Work In Process topped out at $384000.0 in Q4 2022 and bottomed at $176000.0 in Q4 2021.
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2022 384,000.00
Dec 31, 2021 176,000.00
Jun 30, 2021 241,000.00